DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ shed 1.80% to $61.22 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.94% to 6,816.63 and Dow Jones Industrial Average falling 0.83% to 48,501.27.

This was the stock's second consecutive day of losses.

Bristol Myers Squibb Co. closed 3.33% short of its 52-week high of $63.33, which the company reached on March 11th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.73% to $246.75, Pfizer Inc. $(PFE)$ fell 2.49% to $26.58, and Abbott Laboratories $(ABT)$ fell 0.45% to $113.61.

Trading volume (12.4 M) remained 1.5 million below its 50-day average volume of 13.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 03, 2026 16:37 ET (21:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.